Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mertelsmann

Showing results (281-290 of 366) with videos related to

Pageof 37
Sort By:
Human Gene Therapy|December 31, 1997
Efficient gene transfer in primitive CD34+/CD38lo human bone marrow cells reselected after long-term exposure to GALV-pseudotyped retroviral vectorH Glimm, H P Kiem, B Darovsky, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1993
Immunomodulatory effects of ultra-low-dose interleukin-2 in cancer patients: a phase-IB studyA Lindemann, P Brossart, K Höffken, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Pluripoietin alpha: a second human hematopoietic colony-stimulating factor produced by the human bladder carcinoma cell line 5637J L Gabrilove, K Welte, P Harris, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancerF Otto, P Schmid, A Mackensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancerS Fetscher, W Brugger, R Engelhardt, et al.
Bone Marrow Transplantation|December 1, 1996
Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donorsJ Finke, W Brugger, H Bertz, et al.
Cancer Research|April 15, 1992
Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alphaM A Brach, H J Gruss, Y Asano, et al.
Haematology and Blood Transfusion|January 1, 1985
Purification to apparent homogeneity and biochemical characterization of human pluripotent hematopoietic colony-stimulating factorK Welte, E Platzer, J L Gabrilove, et al.
Immunogenetics|January 1, 1996
Recognition by human Vgamma9/Vdelta2 T cells of melanoma cells upon fusion with Daudi cellsO Viale, P van der Bruggen, E Meuer, et al.
In Vivo (Athens, Greece)|May 1, 1997
Paracrine stimulation of keratinocytes in vitro and continuous delivery of epidermal growth factor to wounds in vivo by genetically modified fibroblasts transfected with a novel chimeric constructF M Rosenthal, L Cao, E Tanczos, et al.
Pageof 37

Showing results (281-290 of 366) with videos related to

Sort By:
Pageof 37
Human Gene Therapy|December 31, 1997
Efficient gene transfer in primitive CD34+/CD38lo human bone marrow cells reselected after long-term exposure to GALV-pseudotyped retroviral vectorH Glimm, H P Kiem, B Darovsky, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1993
Immunomodulatory effects of ultra-low-dose interleukin-2 in cancer patients: a phase-IB studyA Lindemann, P Brossart, K Höffken, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Pluripoietin alpha: a second human hematopoietic colony-stimulating factor produced by the human bladder carcinoma cell line 5637J L Gabrilove, K Welte, P Harris, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancerF Otto, P Schmid, A Mackensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancerS Fetscher, W Brugger, R Engelhardt, et al.
Bone Marrow Transplantation|December 1, 1996
Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donorsJ Finke, W Brugger, H Bertz, et al.
Cancer Research|April 15, 1992
Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alphaM A Brach, H J Gruss, Y Asano, et al.
Haematology and Blood Transfusion|January 1, 1985
Purification to apparent homogeneity and biochemical characterization of human pluripotent hematopoietic colony-stimulating factorK Welte, E Platzer, J L Gabrilove, et al.
Immunogenetics|January 1, 1996
Recognition by human Vgamma9/Vdelta2 T cells of melanoma cells upon fusion with Daudi cellsO Viale, P van der Bruggen, E Meuer, et al.
In Vivo (Athens, Greece)|May 1, 1997
Paracrine stimulation of keratinocytes in vitro and continuous delivery of epidermal growth factor to wounds in vivo by genetically modified fibroblasts transfected with a novel chimeric constructF M Rosenthal, L Cao, E Tanczos, et al.
Pageof 37